2
Most read
7
Most read
12
Most read
Johnny Kenth – ST3 Anaesthesia,
Royal Blackburn Hospital
Inotropes
Definition:
An inotrope is an agent that alters force of contraction of cardiac muscle without
affecting the pre or after load. E.g. +ve inotropes  contractility
Classification
• Class 1  intracellular [ca], include:
• Ca ions
• Drugs  cAMP - adrenoagonists, PDIs, Glucagon
• Drugs affecting Na-K ATPase - digoxin
 Class 2  sensitivity actomyosin to Ca ions – Levosimendan
 Class 3 Metabolic / endocrinological – T3
Catecholamine Synthesis
Inotropes + vasopressors
Site of action
du Toit E et al. Heart 2001;86:81-87
Drug Alpha-1 Beta-1 Beta-2 Dopaminergic Predominant Clinical Effects
Phenylephrine *** 0 0 0 SVR ↑ ↑, CO ↔/↑
Noreadrenaline *** ** 0 0 SVR ↑ ↑, CO ↔/↑
Adrenaline *** *** ** 0
CO ↑ ↑, SVR ↓ (low dose)
SVR/↑ (higher dose)
Dopamine
(mcg/kg/min)
0.5 to 2 0 * 0 ** CO
5 to 10 * ** 0 ** CO ↑, SVR ↑
10 to 20 ** ** 0 ** SVR ↑ ↑
Dobutamine 0/* *** ** 0 CO ↑, SVR ↓
Isoproterenol 0 *** *** 0 CO ↑, SVR ↓
*** Very Strong Effect, ** Moderate effect, * Weak effect, 0 No effect.
Actions
Acts on 1, 2, + 1 receptors.
• CVS:  HR (chronotropic) + contractility (inotropic -force of contraction)
CO; also +ve dromotropic, bathmotropic & -ve lusitropic
SBP rises, but with low doses DBP may fall due to (2 vasodilation and
increased blood flow through skeletal muscle beds (2).
At higher doses = 1 mediated vasoconstrictor effects
• RS: Bronchial smooth muscle is relaxed 2 = bronchodilation
• Other: Adrenaline mobilises glucose from glycogen and raises blood
sugar. Pupillary dilation (mydriasis) occurs.
• Side effects Ventricular arrhythmias, hypertension. Care with halothane
anaesthesia as arrhythmias may occur
Adrenaline (Epinephrine)
Prepare the body for a "fight or flight" response.
Site of action
du Toit E et al. Heart 2001;86:81-87
• Noradrenaline
Acts mainly on 1 receptors with few effects on  receptors.
 BP by vasoconstriction. Less likely to cause tachycardia than
adrenaline.
Indications Septic shock where peripheral vasodilation may be causing
hypotension.
Cautions Acts by  afterload and therefore not appropriate for use in
patients in cardiogenic shock.  Blood supply to kidneys and peripheries
Dose - 0.01-1 mcg/kg/min
• Dopamine
Acts on D, 1, 2 and 1 receptors, depending on the dose administered.
Actions Dose dependent
1-2mcg/kg/min - acts on D receptors usually  UO
2-10mcg/kg/min - acts on  receptors   CO
>10mcg/kg/min - additional effects on 1 receptors  vasoconstrict.
• Dobutamine
Acts on 1 & 2, with minimal action on 1 receptors.
It  CO and  afterload (2 effects).
Indications Cardiogenic shock.
Dose 2-30mcg/kg/min
• Dopexamine
Acts on 2 and D receptors.
 CO and afterload.  blood supply to kidneys and ? + GI tract.
Dose 0.5-6mcg/kg/min
• Salbutamol
Acts on 2 receptors
Actions Relaxes bronchial smooth muscle i.e. bronchodilation;  HR
Indications Severe acute asthma.
Dose By infusion 5-20mcg/min. IV bolus 1- 5mcg/kg
Site of action
du Toit E et al. Heart 2001;86:81-87
• e.g. aminophylline, enoximone, milrinone
• Prevent breakdown of cAMP by enzyme phosphodiesterase: 
intracellular [Ca] in myocytes - augments catecholamines at 1 and 2
receptors.
• Actions: Inodilation, i.e.  rate and force of contraction, peripheral
vasodilation in skeletal muscle, bronchodilation.
Indications
• Aminophylline: asthma, cardiac failure.
• Enoximone: cardiac surgery - patients failing to respond to dobutamine
Phosphodiesterase inhibitors
• Action : directly on 1 + 2 receptors,
indirectly on 1 receptors via NA release.
• Side effects May cause tachycardia and hypertension. Possible
arrhythmias if used with halothane. C/I MAOs, SNRI
• Indications Low blood pressure due to vasodilation e.g. following
spinal or epidural anaesthesia and drug overdoses. Better
vasopressor to use in pregnancy as it does not reduce placental blood
flow.
• Dose 3-10 mg boluses iv, repeat until effective. Maximum dose is
60mg.
• Length of action 5-15 minutes, repeated doses less effective (i.e. it
demonstrates tachyphylaxis)
EPHEDRINE
• Metaraminol
Acts directly on 1 receptors
also causes some noradrenaline and adrenaline release.
Actions  MAP and  CO.
Less likely to cause a reflex bradycardia than methoxamine or
phenylephrine.
Dose - 0.5 1mg boluses iv, 2-10mg s/c or im, by infusion at 1-20mg/hr.
• Phenylephrine
Acts directly on 1 receptors.
Action Hypertension and a reflex  HR.
Dose, 0.1-0.5mg iv, by infusion 0.1 – 1 mcg/kg/min
• Methoxamine
acts on 1 receptors.
Actions.  MAP + reflex  HR, and therefore it is good for hypotension
with tachycardia. Useful during spinal anaesthesia.
Side effects May produce bradycardia
Dose 2-4mg boluses IV.
Other pressors:
 Naturally occurring nonapetide hormone, produced in post
hypothamalamus by PVN SON, stored + released post pituitary.
 Acts on V1, V2, V3 and OTR - GPCR
 V1: receptors are found on vascular smooth muscle of the systemic,
splanchnic, renal, and coronary circulations  vasoconstriction (Gq)
 V2: predominantly located in the distal tubule and collecting ducts of
the kidney  aquaporin chn   water re-absorption
 Uses:
• Sepsis:  NA usage, VASST, as safe as NA, VANISH -
• Cardiac Arrest: ?  survival ( Krismer et al)
Asystole: ? survival to ED adm, + discharge. (Wenzel et), no
affect mortality.
VASOPRESSIN
 Direct: Inhibits cardiac Na-K ATPase:
•  Intracellular Na
•  Na / Ca exchange   intracellular Ca
•  Ca release from SR   actin-myosin cross linkage
•   contractile force
 Inirect: inhibits neuronal Na-K ATPase
•  Vagal activity
 PK
• Long T1/2 needs LD
• Renal clearence
Large VD
Digoxin
Clinical
Application
1st Line Agent 2nd Line Agent
Septic Shock Noradrenaline Adrenaline
Dopamine Vasopressin
Heart Failure Dopamine PDIs (Milrinone)
Dobutamine + Norad
Cardiogenic
Shock
Dobutamine
Levosimendan
+/- Norad SBP<80 PDIs
Anaphylactic
Shock Adrenaline Vasopressin
Neurogenic Shock Norad
Hypotension
Anesthesia-
induced
Ephedrine / Metaraminol /
Phenylephrine **Adrenaline
Following
CABG Epinephrine (Adrenalin)
 72 year-old woman with DM Type II, hypertension and Stage II
CKD, recurrent UTIs, is transferred from a MAU. Her vitals upon
arrival are as follows: Temp 39C, BP 70/45, Hr 140, RR 20, O2 Sat
95% 4L02 Lab findings: WCC 24, Cr 3.5, Lac 3.4, Positive Ur Dp,
CRP 241
 After adequate IVF resuscitation, pt continues to remain
hypotensive MAP 40-50s + tachycardic HR 110-130s. What is the
most appropriate 1st line vasopressor/inotropic agent?
A. Adrenaline
B. Dobutamine
C. Noreadrenaline
D. Dopamine
 64 year-old man with PMHx IHD; prev. MI and PCI (2004; drug-
eluting stents), ischemic cardiomyopathy (EF 30-35%) with ICD
(2007). ED 1/52 Hx progressively worsening SOB at rest,
orthopnea and bilateral lower extremity oedema, after running out of
all medications about 10 days ago.
 In ED, vitals: Temp 36.6 C, BP 88/48, Hr 75, RR 25, O2 Sat 91%
on RA. CXR reveals vascular congestion and bilateral pleural
effusion. Bedside ultrasound reveals significantly diminished EF.
 What is the most appropriate 1st line vasoactive agent?
A. Adrenaline
B. Dobutamine
C. Noreadrenaline
D. Dopamine
 76 year-old cachexic female with PMHx: COPD, HTN and
Osteoporosis was initially admitted under medics for acute exac
COPD. Had fall on ward # L-NOF.
 Underwent CNB-spinal anaesthesia. 15 mins post induction her
BP was 64/44, P108, RR18, SpO2 99% RA.
 What is the most appropriate 1st line vasopressor/inotropic
agent?
A. Adrenaline
B. Dobutamine
C. Dopexamine
D. Dopamine
E. Metaradine
Inotropes + vasopressors
Inotropes + vasopressors
Inotropes + vasopressors

More Related Content

PPTX
Inotropes
PPTX
Inotropes and vasopressors
PPTX
A Practical Approach to Ionotropes and vasopressors
PPTX
Pacemaker powerpoint presentation med surg
PPT
Renal replacement therapy
PPTX
MANAGEMENT OF SHOCK
PPTX
Septic shock management (1)
PPT
Inotropes
Inotropes
Inotropes and vasopressors
A Practical Approach to Ionotropes and vasopressors
Pacemaker powerpoint presentation med surg
Renal replacement therapy
MANAGEMENT OF SHOCK
Septic shock management (1)
Inotropes

What's hot (20)

PPSX
Inotropes & vasopressors
PPTX
Ionotropes and vasopressors
PPTX
Vassopressors and Inotropes
PPTX
Sodium bicarbonate in acidosis
PPTX
INOTROPES IN SHOCK.pptx
PPTX
Inotropes & vasoactive agents
PPTX
Dexmedetomidine
PPT
ANESTHESIA FOR TOF SURGERY
PPT
Magnesium and anaesthesia
PPTX
Vasoactive and inotropic agents
PPTX
Inotrope use in icu patient fink
PPTX
Glycopyrrolate
PPTX
Inotropes
PPTX
Anaesthetic considerations in cardiac patients undergoing non
PPT
Vasopressors and inotropes
PPTX
Pace maker anaesthesia
PPTX
Arterial line analysis
PPTX
sugmmadex.pptx
PPTX
Esmolol ( Emergency Friend of Anesthesiologist)
PPTX
Nor adrenalin
Inotropes & vasopressors
Ionotropes and vasopressors
Vassopressors and Inotropes
Sodium bicarbonate in acidosis
INOTROPES IN SHOCK.pptx
Inotropes & vasoactive agents
Dexmedetomidine
ANESTHESIA FOR TOF SURGERY
Magnesium and anaesthesia
Vasoactive and inotropic agents
Inotrope use in icu patient fink
Glycopyrrolate
Inotropes
Anaesthetic considerations in cardiac patients undergoing non
Vasopressors and inotropes
Pace maker anaesthesia
Arterial line analysis
sugmmadex.pptx
Esmolol ( Emergency Friend of Anesthesiologist)
Nor adrenalin
Ad

Similar to Inotropes + vasopressors (20)

PPTX
Drugs in pediatrics 2018 feb update ..pptx
PPTX
cardiovascular_agents_(1).pptx
PDF
Pharmacology of-vasopressors-and-inotropes
PPTX
Adrenergic agonist & antagonist
PPTX
Vasopressors
PDF
inotropesandtheirchoice2-141011140848-conversion-gate01 (1).pdf
PPT
Inotropesfs
PPT
Autonomic nervous system drugs
PPTX
Inotropes & Vasopressors presentation (1).pptx
PPTX
Inotropes by elza
PPTX
Hypertensive emergencies in children
PPTX
inotropes
PDF
Class drug therapy of shock
PPTX
Vasoactive agents
PPTX
inotropic drugs and vassopressors drugs.pptx
PDF
Emergency medications drugs
PPT
anesthetics.pptanesthetics.pptanesthetics.ppt
PPTX
Pheochromocytoma Anesthesia Consideration
PPTX
Shock...............................pptx
PPT
adrenergic pharmacology.ppt for public health
Drugs in pediatrics 2018 feb update ..pptx
cardiovascular_agents_(1).pptx
Pharmacology of-vasopressors-and-inotropes
Adrenergic agonist & antagonist
Vasopressors
inotropesandtheirchoice2-141011140848-conversion-gate01 (1).pdf
Inotropesfs
Autonomic nervous system drugs
Inotropes & Vasopressors presentation (1).pptx
Inotropes by elza
Hypertensive emergencies in children
inotropes
Class drug therapy of shock
Vasoactive agents
inotropic drugs and vassopressors drugs.pptx
Emergency medications drugs
anesthetics.pptanesthetics.pptanesthetics.ppt
Pheochromocytoma Anesthesia Consideration
Shock...............................pptx
adrenergic pharmacology.ppt for public health
Ad

Recently uploaded (20)

PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
Post Op complications in general surgery
PPTX
Manage HIV exposed child and a child with HIV infection.pptx
PDF
Transcultural that can help you someday.
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
Wheat allergies and Disease in gastroenterology
PPT
Infections Member of Royal College of Physicians.ppt
PPT
Dermatology for member of royalcollege.ppt
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
neurology Member of Royal College of Physicians (MRCP).ppt
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
y4d nutrition and diet in pregnancy and postpartum
Post Op complications in general surgery
Manage HIV exposed child and a child with HIV infection.pptx
Transcultural that can help you someday.
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
09. Diabetes in Pregnancy/ gestational.pptx
Acute Coronary Syndrome for Cardiology Conference
Wheat allergies and Disease in gastroenterology
Infections Member of Royal College of Physicians.ppt
Dermatology for member of royalcollege.ppt
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
Copy of OB - Exam #2 Study Guide. pdf
Electrolyte Disturbance in Paediatric - Nitthi.pptx
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha

Inotropes + vasopressors

  • 1. Johnny Kenth – ST3 Anaesthesia, Royal Blackburn Hospital
  • 2. Inotropes Definition: An inotrope is an agent that alters force of contraction of cardiac muscle without affecting the pre or after load. E.g. +ve inotropes  contractility Classification • Class 1  intracellular [ca], include: • Ca ions • Drugs  cAMP - adrenoagonists, PDIs, Glucagon • Drugs affecting Na-K ATPase - digoxin  Class 2  sensitivity actomyosin to Ca ions – Levosimendan  Class 3 Metabolic / endocrinological – T3
  • 5. Site of action du Toit E et al. Heart 2001;86:81-87
  • 6. Drug Alpha-1 Beta-1 Beta-2 Dopaminergic Predominant Clinical Effects Phenylephrine *** 0 0 0 SVR ↑ ↑, CO ↔/↑ Noreadrenaline *** ** 0 0 SVR ↑ ↑, CO ↔/↑ Adrenaline *** *** ** 0 CO ↑ ↑, SVR ↓ (low dose) SVR/↑ (higher dose) Dopamine (mcg/kg/min) 0.5 to 2 0 * 0 ** CO 5 to 10 * ** 0 ** CO ↑, SVR ↑ 10 to 20 ** ** 0 ** SVR ↑ ↑ Dobutamine 0/* *** ** 0 CO ↑, SVR ↓ Isoproterenol 0 *** *** 0 CO ↑, SVR ↓ *** Very Strong Effect, ** Moderate effect, * Weak effect, 0 No effect.
  • 7. Actions Acts on 1, 2, + 1 receptors. • CVS:  HR (chronotropic) + contractility (inotropic -force of contraction) CO; also +ve dromotropic, bathmotropic & -ve lusitropic SBP rises, but with low doses DBP may fall due to (2 vasodilation and increased blood flow through skeletal muscle beds (2). At higher doses = 1 mediated vasoconstrictor effects • RS: Bronchial smooth muscle is relaxed 2 = bronchodilation • Other: Adrenaline mobilises glucose from glycogen and raises blood sugar. Pupillary dilation (mydriasis) occurs. • Side effects Ventricular arrhythmias, hypertension. Care with halothane anaesthesia as arrhythmias may occur Adrenaline (Epinephrine) Prepare the body for a "fight or flight" response.
  • 8. Site of action du Toit E et al. Heart 2001;86:81-87
  • 9. • Noradrenaline Acts mainly on 1 receptors with few effects on  receptors.  BP by vasoconstriction. Less likely to cause tachycardia than adrenaline. Indications Septic shock where peripheral vasodilation may be causing hypotension. Cautions Acts by  afterload and therefore not appropriate for use in patients in cardiogenic shock.  Blood supply to kidneys and peripheries Dose - 0.01-1 mcg/kg/min • Dopamine Acts on D, 1, 2 and 1 receptors, depending on the dose administered. Actions Dose dependent 1-2mcg/kg/min - acts on D receptors usually  UO 2-10mcg/kg/min - acts on  receptors   CO >10mcg/kg/min - additional effects on 1 receptors  vasoconstrict.
  • 10. • Dobutamine Acts on 1 & 2, with minimal action on 1 receptors. It  CO and  afterload (2 effects). Indications Cardiogenic shock. Dose 2-30mcg/kg/min • Dopexamine Acts on 2 and D receptors.  CO and afterload.  blood supply to kidneys and ? + GI tract. Dose 0.5-6mcg/kg/min • Salbutamol Acts on 2 receptors Actions Relaxes bronchial smooth muscle i.e. bronchodilation;  HR Indications Severe acute asthma. Dose By infusion 5-20mcg/min. IV bolus 1- 5mcg/kg
  • 11. Site of action du Toit E et al. Heart 2001;86:81-87
  • 12. • e.g. aminophylline, enoximone, milrinone • Prevent breakdown of cAMP by enzyme phosphodiesterase:  intracellular [Ca] in myocytes - augments catecholamines at 1 and 2 receptors. • Actions: Inodilation, i.e.  rate and force of contraction, peripheral vasodilation in skeletal muscle, bronchodilation. Indications • Aminophylline: asthma, cardiac failure. • Enoximone: cardiac surgery - patients failing to respond to dobutamine Phosphodiesterase inhibitors
  • 13. • Action : directly on 1 + 2 receptors, indirectly on 1 receptors via NA release. • Side effects May cause tachycardia and hypertension. Possible arrhythmias if used with halothane. C/I MAOs, SNRI • Indications Low blood pressure due to vasodilation e.g. following spinal or epidural anaesthesia and drug overdoses. Better vasopressor to use in pregnancy as it does not reduce placental blood flow. • Dose 3-10 mg boluses iv, repeat until effective. Maximum dose is 60mg. • Length of action 5-15 minutes, repeated doses less effective (i.e. it demonstrates tachyphylaxis) EPHEDRINE
  • 14. • Metaraminol Acts directly on 1 receptors also causes some noradrenaline and adrenaline release. Actions  MAP and  CO. Less likely to cause a reflex bradycardia than methoxamine or phenylephrine. Dose - 0.5 1mg boluses iv, 2-10mg s/c or im, by infusion at 1-20mg/hr. • Phenylephrine Acts directly on 1 receptors. Action Hypertension and a reflex  HR. Dose, 0.1-0.5mg iv, by infusion 0.1 – 1 mcg/kg/min • Methoxamine acts on 1 receptors. Actions.  MAP + reflex  HR, and therefore it is good for hypotension with tachycardia. Useful during spinal anaesthesia. Side effects May produce bradycardia Dose 2-4mg boluses IV. Other pressors:
  • 15.  Naturally occurring nonapetide hormone, produced in post hypothamalamus by PVN SON, stored + released post pituitary.  Acts on V1, V2, V3 and OTR - GPCR  V1: receptors are found on vascular smooth muscle of the systemic, splanchnic, renal, and coronary circulations  vasoconstriction (Gq)  V2: predominantly located in the distal tubule and collecting ducts of the kidney  aquaporin chn   water re-absorption  Uses: • Sepsis:  NA usage, VASST, as safe as NA, VANISH - • Cardiac Arrest: ?  survival ( Krismer et al) Asystole: ? survival to ED adm, + discharge. (Wenzel et), no affect mortality. VASOPRESSIN
  • 16.  Direct: Inhibits cardiac Na-K ATPase: •  Intracellular Na •  Na / Ca exchange   intracellular Ca •  Ca release from SR   actin-myosin cross linkage •   contractile force  Inirect: inhibits neuronal Na-K ATPase •  Vagal activity  PK • Long T1/2 needs LD • Renal clearence Large VD Digoxin
  • 17. Clinical Application 1st Line Agent 2nd Line Agent Septic Shock Noradrenaline Adrenaline Dopamine Vasopressin Heart Failure Dopamine PDIs (Milrinone) Dobutamine + Norad Cardiogenic Shock Dobutamine Levosimendan +/- Norad SBP<80 PDIs Anaphylactic Shock Adrenaline Vasopressin Neurogenic Shock Norad Hypotension Anesthesia- induced Ephedrine / Metaraminol / Phenylephrine **Adrenaline Following CABG Epinephrine (Adrenalin)
  • 18.  72 year-old woman with DM Type II, hypertension and Stage II CKD, recurrent UTIs, is transferred from a MAU. Her vitals upon arrival are as follows: Temp 39C, BP 70/45, Hr 140, RR 20, O2 Sat 95% 4L02 Lab findings: WCC 24, Cr 3.5, Lac 3.4, Positive Ur Dp, CRP 241  After adequate IVF resuscitation, pt continues to remain hypotensive MAP 40-50s + tachycardic HR 110-130s. What is the most appropriate 1st line vasopressor/inotropic agent? A. Adrenaline B. Dobutamine C. Noreadrenaline D. Dopamine
  • 19.  64 year-old man with PMHx IHD; prev. MI and PCI (2004; drug- eluting stents), ischemic cardiomyopathy (EF 30-35%) with ICD (2007). ED 1/52 Hx progressively worsening SOB at rest, orthopnea and bilateral lower extremity oedema, after running out of all medications about 10 days ago.  In ED, vitals: Temp 36.6 C, BP 88/48, Hr 75, RR 25, O2 Sat 91% on RA. CXR reveals vascular congestion and bilateral pleural effusion. Bedside ultrasound reveals significantly diminished EF.  What is the most appropriate 1st line vasoactive agent? A. Adrenaline B. Dobutamine C. Noreadrenaline D. Dopamine
  • 20.  76 year-old cachexic female with PMHx: COPD, HTN and Osteoporosis was initially admitted under medics for acute exac COPD. Had fall on ward # L-NOF.  Underwent CNB-spinal anaesthesia. 15 mins post induction her BP was 64/44, P108, RR18, SpO2 99% RA.  What is the most appropriate 1st line vasopressor/inotropic agent? A. Adrenaline B. Dobutamine C. Dopexamine D. Dopamine E. Metaradine

Editor's Notes

  • #7: Phenylephrine (Neo) has purely Alpha-adrenergic agonist activity and therefore results in vasoconstriction with minimal cardiac inotropy or chronotropy. MAP is augmented by raising SVR. Norepi (Levo) acts both on Alpha-1 and Beta-1 adrenergic receptors, thus producing potent vasoconstriction as well as a less pronounced increase in CO. A reflex bradycardia ususally occurs in response to increased MAP, such that mild chronotropic effect is canceled out and HR remains unchanged. Most commonly used in septic shock. Epinephrine potent beta-1 adrenergic receptor and moderate beta-2 and alpha-1 adrenergic receptors. Epi is often used for treatment of anaphylaxis, as second line agent in septic shock. Dopamine is dose depended. At dose 1-2 mcg/kg/min, predominant effect on dopamine-1 receptors in renal, mesenteric, cerebral and coronary beds, resulting in selective vasodilation. At 5-10mcg/kg/min, stimulates beta-1 and increases CO. >10mcg/kg/min, alpha adrenergic receptors and produce vasoconstriction with increased SVR. Dobutamine is not a vasopressor but rather a inotrope that causes vasodilation – increasea inotropy and chronotropy and reduces LV filling pressure. Isoproterenol is also primarily an inotropic and chronotropic agent rather than a vasopressor. Beta-1 primary. Unlike Dobutamine, has prominent chronotropic effect. Utility limited to hypotensive patients, where hypotension results from bradycardia.
  • #8: -Catecholeamines broken down : COMT central; MAO- central + periphery - NA – adren PNMT= Phenylethanolamine N-methyltransferase Chronotropic (Heart rate) · Dromotropic (Conduction velocity)  Inotropic (Contractility) · Bathmotropic (Excitability) · Lusitropic (Relaxation) A dromotropic agent is one which affects the conduction speed in the AV node, and subsequently the rate of electrical impulses in the heart.
  • #16: V3 = mainly in pituitary, cause acth relapse
  • #17: V3 = mainly in pituitary, cause acth relapse
  • #19: Answer - NORAD Pt is in septic shock secondary to UTI.
  • #20: Answer: Dopamine Pt is in acute decompensated heart failure with pending cardiogenic shock. Dopamine can be used as first line agent to increase CO; however, in heart failure with cardiogenic shock, Dobutamine and norad are first line agents.
  • #21: Metaradrine = metaraminol